ATE138929T1 - Verfahren zur anomizierung von nukleosiden - Google Patents

Verfahren zur anomizierung von nukleosiden

Info

Publication number
ATE138929T1
ATE138929T1 AT93306886T AT93306886T ATE138929T1 AT E138929 T1 ATE138929 T1 AT E138929T1 AT 93306886 T AT93306886 T AT 93306886T AT 93306886 T AT93306886 T AT 93306886T AT E138929 T1 ATE138929 T1 AT E138929T1
Authority
AT
Austria
Prior art keywords
nucleosides
anomizing
anomer
anomeric mixture
nucleoside
Prior art date
Application number
AT93306886T
Other languages
English (en)
Inventor
Thomas Charles Britton
Tourneau Michael Edward Le
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE138929T1 publication Critical patent/ATE138929T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/048—Pyridine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT93306886T 1992-09-01 1993-08-31 Verfahren zur anomizierung von nukleosiden ATE138929T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93879192A 1992-09-01 1992-09-01

Publications (1)

Publication Number Publication Date
ATE138929T1 true ATE138929T1 (de) 1996-06-15

Family

ID=25471966

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93306886T ATE138929T1 (de) 1992-09-01 1993-08-31 Verfahren zur anomizierung von nukleosiden

Country Status (15)

Country Link
US (1) US5420266A (de)
EP (1) EP0587364B1 (de)
JP (1) JP3462893B2 (de)
KR (1) KR100252451B1 (de)
AT (1) ATE138929T1 (de)
BR (1) BR9303658A (de)
CA (1) CA2105112C (de)
DE (1) DE69302977T2 (de)
DK (1) DK0587364T3 (de)
ES (1) ES2090880T3 (de)
GR (1) GR3020426T3 (de)
HU (1) HU214980B (de)
IL (1) IL106840A (de)
MX (1) MX9305301A (de)
TW (1) TW356472B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627160A (en) * 1993-05-25 1997-05-06 Yale University L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
TW374087B (en) * 1993-05-25 1999-11-11 Univ Yale L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
US5637688A (en) * 1994-12-13 1997-06-10 Eli Lilly And Company Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride
US5869461A (en) * 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
US5633367A (en) * 1995-03-24 1997-05-27 Eli Lilly And Company Process for the preparation of a 2-substituted 3,3-difluorofuran
CA2171518A1 (en) * 1995-03-24 1996-09-25 Douglas Patton Kjell Process for the preparation of 2,2'-anhydro- and 2' -keto-1-(3', 5'-di-o-protected-.beta.-d-arabinofuranosyl) nucleosides
US6013790A (en) * 1996-09-25 2000-01-11 Board Of Regents University Of Nebraska-Lincoln Heavily fluorinated sugar analogs
US6248878B1 (en) * 1996-12-24 2001-06-19 Ribozyme Pharmaceuticals, Inc. Nucleoside analogs
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
PL359169A1 (en) 2000-05-26 2004-08-23 Idenix (Cayman) Limited Methods and compositions for treating flaviviruses and pestiviruses
KR100467016B1 (ko) * 2002-05-30 2005-01-24 삼성전자주식회사 반도체기판의 세정방법
CN101172993A (zh) 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′-c-甲基-3′-o-l-缬氨酸酯核糖呋喃基胞苷
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
KR20050035194A (ko) 2002-06-28 2005-04-15 이데닉스 (케이만) 리미티드 플라비비리다에 감염 치료용 2'-c-메틸-3'-o-l-발린에스테르 리보푸라노실 사이티딘
AU2003298658A1 (en) 2002-11-15 2004-06-15 Idenix (Cayman) Limited 2'-branched nucleosides and flaviviridae mutation
US7598373B2 (en) 2002-12-12 2009-10-06 Idenix Pharmaceuticals, Inc. Process for the production of 2-C-methyl-D-ribonolactone
RU2358979C2 (ru) * 2003-05-30 2009-06-20 Фармассет, Инк. Модифицированные фторированные аналоги нуклеозида
CN101023094B (zh) * 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
ES2725457T3 (es) 2004-09-14 2019-09-24 Gilead Pharmasset Llc Preparación de ribofuranosil pirimidinas y purinas 2'fluoro-2'-alquil-sustituidas u otras opcionalmente sustituidas y sus derivados
DE602005019626D1 (de) * 2005-03-04 2010-04-08 Fresenius Kabi Oncology Ltd Zwischenprodukt und verfahren zur herstellung von an beta-anomeren angereicherten 2'-desoxy,2',2'-difluor-d-ribufuranosylnukleosiden
US7781576B2 (en) 2005-12-23 2010-08-24 Idenix Pharmaceuticals, Inc. Process for preparing a synthetic intermediate for preparation of branched nucleosides
US7964580B2 (en) * 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
US8173621B2 (en) * 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
CL2009002206A1 (es) 2008-12-23 2011-08-26 Gilead Pharmasset Llc Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
AR074897A1 (es) * 2008-12-23 2011-02-23 Pharmasset Inc Fosforamidatos de nucleosidos
MX2011006890A (es) * 2008-12-23 2011-07-20 Pharmasset Inc Analogos de nucleosidos.
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
TWI576352B (zh) 2009-05-20 2017-04-01 基利法瑪席特有限責任公司 核苷磷醯胺
AP2012006535A0 (en) 2010-03-31 2012-10-31 Gilead Pharmasset Llc Stereoselective synthesis of phosphorous containing actives
PL3290428T3 (pl) 2010-03-31 2022-02-07 Gilead Pharmasset Llc Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
ES2716158T3 (es) 2010-11-30 2019-06-10 Gilead Pharmasset Llc 2'-spiro-nucleótidos para el tratamiento de hepatitis C
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
CN102603838B (zh) * 2012-02-14 2015-02-18 江苏八巨药业有限公司 一种制备吉西他滨盐酸盐的方法
EA201690473A1 (ru) 2013-08-27 2017-03-31 ГАЙЛИД ФАРМАССЕТ ЭлЭлСи Комбинированный состав двух противовирусных соединений
AU2019296174B2 (en) 2018-06-29 2021-10-07 Changchun Changcheng Pharmaceutical Technology Co., LTD Phosphorus-containing prodrugs of gemcitabine
CN121949418B (zh) * 2026-04-01 2026-07-28 山东安弘制药有限公司 一种盐酸吉西他滨的制备方法

Also Published As

Publication number Publication date
DE69302977T2 (de) 1996-10-31
JP3462893B2 (ja) 2003-11-05
US5420266A (en) 1995-05-30
ES2090880T3 (es) 1996-10-16
KR100252451B1 (ko) 2000-04-15
DK0587364T3 (da) 1996-07-01
GR3020426T3 (en) 1996-10-31
TW356472B (en) 1999-04-21
CA2105112C (en) 2005-08-02
IL106840A0 (en) 1993-12-08
IL106840A (en) 1998-09-24
JPH06157571A (ja) 1994-06-03
KR940007053A (ko) 1994-04-26
MX9305301A (es) 1994-06-30
HU9302452D0 (en) 1993-11-29
CA2105112A1 (en) 1994-03-02
BR9303658A (pt) 1994-03-22
HU214980B (hu) 1998-08-28
HUT65137A (en) 1994-04-28
DE69302977D1 (de) 1996-07-11
EP0587364B1 (de) 1996-06-05
EP0587364A1 (de) 1994-03-16

Similar Documents

Publication Publication Date Title
DE69302977D1 (de) Verfahren zur Anomizierung von Nukleosiden
ATE155476T1 (de) Verfahren zur herstellung von mit alpha-anomeren angereichterten 2-deoxy-2,2-difluor-d- ribofuranosyl sulfonaten
DE69314239D1 (de) Verfahren zur Stereoselektivglycosylierung
FI905535A7 (fi) Menetelmä havupuiden monistamiseksi somaattisella embryogeneesillä
DE3884826D1 (de) Vorrichtung zum Verhindern der Verschmutzung von Motorfahrzeug-Heckleuchteneinheiten.
ATE140923T1 (de) Verfahren zur herstellung von n4-acyl-5'-desoxy-5-fluorocytidinderivate
ATE149505T1 (de) Verfahren zur trennung von 2-deoxy-2,2-difluor-d- ribofuranosyl-alkyl-sulfonat-anomeren
DK572788A (da) Polysvovlsyreestere af bis-aldonamider og derivater deraf samt fremgangsmaade til fremstilling af samme
DE69020481D1 (de) Verfahren und Vorrichtung zum Biegen von Glas.
ATE189195T1 (de) Verfahren und vorrichtung zum biegen von glasscheiben
DE69311000D1 (de) Verfahren zur Herstellung von mit Alpha-Anomeren angereicherten 1-Halogen-2-Deoxy-2,2-Difluor-D-Ribofuranosyl-Derivaten
EP0405913A3 (en) Hydrophobic nucleic acid probe
DE3787273D1 (de) Vorrichtung und Verfahren zum Durchführen von optischen Fasern durch röhrenförmige Artikeln.
DE69003633D1 (de) Verfahren zum biegen von glastafeln.
DE58907015D1 (de) Verfahren zum zusammenbauen von zwei glastafeln zu einer isolierglasscheibe.
EP0328959A3 (de) Verfahren zur Reinigung von langkettigen Alkylglucosiden
DE69010030D1 (de) Verfahren zur Produktion von Fruktose-1,6-diphosphat.
PT92726A (pt) Processo de eliminacao de etanol de bebidas produzidas por fermentacao
DE3886209D1 (de) Mit flossen versehenes stabilisierungsheckteil für ein pfeilgeschoss.
DE3781913D1 (de) Verfahren zur herstellung von makrolid-verbindungen.
ATE137562T1 (de) Verfahren zur ausgestaltung von brunnenbereichen
DE58905748D1 (de) Verfahren und vorrichtung zum herstellen von hohlglaesern aus einem hohlglasteil und mindestens einem massivglasteil.
ATE312116T1 (de) Verfahren zur herstellung von nukleosid-derivaten
DE59006740D1 (de) Vorrichtung zum Innenlackieren von Hohlkörpern.
ATE119168T1 (de) Verfahren zum abspalten von delta-4-ungesättigter uronsäure aus glycosaminoglykanen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee